1-Methyl-4-phenylpyridinium and 3-nitropropionic acid diminish cortical synthesis of kynurenic acid via interference with kynurenine aminotransferases in rats

Neuroscience Letters

Volumn 330, Issue 1, 2002, Pages 49-52

  Luchowski, Piotr ^a   Luchowska, Elzbieta ^a   Turski, Waldemar A ^a,b   Urbanska, Ewa M ^a,b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

1 Methyl 4 phenylpyridinium; 3 Nitropropionic acid; Kynurenic acid; Kynurenine aminotransferase; Rat

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 3 NITROPROPIONIC ACID; GLUTAMATE RECEPTOR ANTAGONIST; ISOENZYME; KYNURENIC ACID; KYNURENINE AMINOTRANSFERASE;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN SLICE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYMATIC ASSAY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; MITOCHONDRION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; CEREBRAL CORTEX; KYNURENIC ACID; MALE; MITOCHONDRIA; NITRO COMPOUNDS; PROPIONIC ACIDS; RATS; RATS, WISTAR; TRANSAMINASES;

EID: 0037072547     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)00735-8     Document Type: Article

References (22)

1. Beal M.F. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol. 31:1992;119-130.
2. Beal M.F., Brouillet E., Jenkins B.G., Ferrante R.J., Kowall N.W., Miller J.M., Storej E., Srivastava R., Rosen B.R., Hyman B.T. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J. Neurosci. 13:1993;4181-4192.
3. Burns R.S., Chiueh C.C., Markey S.P., Ebert M.H., Jacobowitz D.M., Kopin I.J. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA. 80:1983;4546-4550.
4. Di Monte D.A., Royland J.E., Irwin I., Langston J.W. Astrocytes as the site for bioactivation of neurotoxins. Neurotoxicology. 17:1996;697-703.
5. Guidetti P., Okuno E., Schwarcz R. Characterization of rat brain kynurenine aminotransferases I and II. J. Neurosci. Res. 50:1997;457-465.
6. Hodgkins P.S., Schwarcz R. Interference with cellular energy metabolism reduces kynurenic acid formation in rat brain slices: reversal by lactate and pyruvate. Eur. J. Neurosci. 10:1998;1986-1994.
7. Langston J.W., Ballard P., Tetrud J.W., Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 219:1983;979-980.
8. Ludolph A.C., He F., Spencer P.S., Hammerstad J., Sabri M. 3-Nitropropionic acid - exogenous animal neurotoxin and possible human striatal toxin. Can. J. Neurol. Sci. 18:1991;492-498.
9. Novelli A., Reilly J.A., Lysko P.G., Henneberry R.C. Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res. 451:1988;205-212.
10. +. Biochem. Biophys. Res. Commun. 134:1986;743-748.
11. Riepe M., Hori N., Ludolph A.C., Carpenter D.O., Spencer P.S., Allen C.N. Inhibition of energy metabolism by 3-nitropropionic acid activates ATP-sensitive potassium channels. Brain Res. 586:1992;61-66.
12. Simpson J.R., Isacson O. Mitochondrial impairment reduces the threshold for in vivo NMDA-mediated neuronal death in the striatum. Exp. Neurol. 121:1993;57-64.
13. +) nigral toxicity in the rat by prior decortication or MK-801 treatment: a stereological estimate of neuronal loss. Neurobiol. Aging. 14:1993;295-301.
14. Stone T.W. Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection. Trends Pharmacol. Sci. 21:2000;149-154.
15. + neurotoxicity by N-methyl-D-aspartate antagonists. Nature. 349:1991;414-418.
16. + seizures. Synapse. 10:1992;120-125.
17. Turski W.A., Gramsbergen J.B.P., Traitler H., Schwarcz R. Rat brain slices produce and liberate kynurenic acid upon exposure to L-kynurenine. J. Neurochem. 52:1989;1629-1636.
18. Urbanska E.M., Blaszczak P., Saran T., Kleinrok Z., Turski W.A. Mitochondrial toxin 3-nitropropionic acid evokes seizures in mice. Eur. J. Pharmacol. 359:1998;55-58.
19. Urbanska E.M., Blaszczak P., Saran T., Kleinrok Z., Turski W.A. AMPA/kainate-related mechanisms contribute to convulsant and proconvulsant effects of 3-nitropropionic acid. Eur. J. Pharmacol. 370:1999;251-256.
20. Urbanska E.M., Kocki T., Saran T., Kleinrok Z., Turski W.A. Impairment of brain kynurenic acid production by glutamate metabotropic receptor agonists. NeuroReport. 8:1997;3501-3505.
21. Weller M., Paul S.M. 3-Nitropropionic acid is an indirect excitotoxin to cultured cerebellar granule neurons. Eur. J. Pharmacol. 248:1993;223-228.
22. Zeevalk G.D., Derr-Yellin E., Nicklas W.J. NMDA receptor involvement in toxicity to dopamine neurons in vitro caused by the succinate dehydrogenase inhibitor 3-nitropropionic acid. J. Neurochem. 64:1995;455-458.